Zhiqiang Liu

Zhiqiang Liu

Auto-generated profile, based on publicly available information

Zhiqiang Liu

Beijing Institute of Basic Medical Sciences Beijing China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2020 in ACS Nano
Verified
Journal Article
Closed access
YLYanxia Lin
Yanxia Lin
JLJianfeng Liu
Jianfeng Liu
RBRui Bai
Rui Bai
JSJinmiao Shi
Jinmiao Shi
XZXiaoming Zhu
Xiaoming Zhu
ZLZhiqiang Liu
Zhiqiang Liu

23 August 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
RBRui Bai
Rui Bai
JLJianfeng Liu
Jianfeng Liu
JZJiao Zhang
Jiao Zhang
JSJinmiao Shi
Jinmiao Shi
ZJZhigeng Jin
Zhigeng Jin
ZLZhiqiang Liu
Zhiqiang Liu
Background: The niche of tissue development in vivo involves the growth matrix, biophysical cues and cell-cell interactions. Although natural extracellular matrixes may provide good supporting for seeding cells in vitro, it is evitable to destroy biophysical cues during decellularization. Reconstructing the bioactivities of extracellular matrix-based scaffolds is essential for their usage in tissue repair. Results: In the study, a hybrid hydrogel was developed by incorporating single-wall carbon nanotubes (SWCNTs) into heart-derived extracellular matrixes. Interestingly, insoluble SWCNTs were well dispersed in hybrid hydrogel solution via the interaction with extracellular matrix proteins. Importantly, an augmented integrin-dependent niche was reconstructed in the hybrid hydrogel, which could work like biophysical cues to activate integrin-related pathway of seeding cells. As supporting scaffolds in vitro, the hybrid hydrogels were observed to significantly promote seeding cell adhesion, differentiation, as well as structural and functional development towards mature cardiac tissues. As injectable carrier scaffolds in vivo, the hybrid hydrogels were then used to delivery stem cells for myocardial repair in rats. Similarly, significantly enhanced cardiac differentiation and maturation(12.5 ± 2.3% VS 32.8 ± 5%) of stem cells were detected in vivo, resulting in improved myocardial regeneration and repair. Conclusions: The study represented a simple and powerful approach for exploring bioactive scaffold to promote stem cell-based tissue repair. Graphic

23 October 2019 in Stem Cells International
Verified
Journal Article
Open access
PDF file
RBRui Bai
Rui Bai
LTLei Tian
Lei Tian
YLYi Li
Yi Li
JZJiao Zhang
Jiao Zhang
YWYujie Wei
Yujie Wei
HLHuiliang Liu
Huiliang Liu
Tissue engineering exploring the combination of scaffolds and seeding cells was proposed as a promising strategy for myocardial repair. However, the therapeutic outcomes varied greatly due to different selection of scaffolds and seeding cells. Herein, the potential of combining bioactive extracellular matrix (ECM) hydrogels and high cardiomyogenic seeding cells was explored for myocardial repair in vitro and in vivo. Temperature-sensitive ECM hydrogels were prepared from decellularized rat hearts, and cardiomyogenic seeding cells were isolated from brown adipose (brown adipose-derived stem cells (BADSCs)). The in vitro studies demonstrated that ECM hydrogel significantly supported the proliferation and cardiomyogenic differentiation of BADSCs. Importantly, the function and maturation of BADSC-derived cardiomyocytes were also promoted as evidenced by Ca2+ transient’s measurement and protein marker expression. After myocardial transplantation, the combination of BADSCs and ECM hydrogels significantly preserved cardiac function and chamber geometry compared with BADSCs or ECM hydrogels alone. Meanwhile, the ECM hydrogel also enhanced BADSC engraftment and myocardial regeneration in vivo. These results indicated that heart-derived ECM hydrogels exerted significant influence on the fate of cardiomyogenic cells toward benefiting myocardial repair, which may explain the enhanced stem cell therapy by the scaffold. Collectively, it indicated that the combination of ECM hydrogel and the cardiomyogenic cells may represent a promising strategy for cardiac tissue engineering.

3 August 2024 in Advanced Functional Materials
Verified
Journal Article
Closed access
YLYang Liu
Yang Liu
ZZZhifa Zhang
Zhifa Zhang
ZZZiteng Zhao
Ziteng Zhao
YXYongde Xu
Yongde Xu
XDXiaofeng Duan
Xiaofeng Duan
ZLZhiqiang Liu
Zhiqiang Liu

1 February 2020 in EBioMedicine
Verified
Journal Article
Open access
YXYongde Xu
Yongde Xu
YYYong Yang
Yong Yang
HZHan Zheng
Han Zheng
CHChao Huang
Chao Huang
XZXiaoming Zhu
Xiaoming Zhu
YTYe Tian
Ye Tian
Intracavernous injection (ICI) of adipose-derived stem cells (ADSCs) has been demonstrated promising for neurogenic erectile dysfunction (ED). However, due to the sponge-like structure of corpus cavernosum (CC) with abundant vessels, ICI was indeed like intravenous injection. Thus, the cell escaping may be a concern of safety and limited therapy, but the issue has not been clearly demonstrated yet. Suspensions of free ADSCs (FAs) and ADSCs-based spheroids (ASs) with suitable size were intracavernously injected at doses of 0.5, 1, 2, or 4 million cells. The cell loss and safety after ICI, erectile function and histopathologic change, etc. were analyzed with multimodality of methods. Most FAs escaped from sponge-like CC after ICI due to their small size, weakening stem-cell therapeutic efficacy. Worse still, the escaped cells were shown to cause widespread pulmonary embolism (PE), and even death in some animals. Further, it was founded that the therapeutic effect of FAs may be ascribed to the larger cell clusters which spontaneously aggregated before ICI and were trapped within CC after ICI. In comparison, cell loss and PE were significantly avoided by transplanting ASs. Importantly, better therapeutic outcomes were detected after ICI of ASs when compared to FAs with the same cell number. Transplantation of size-specific ASs instead of single-cell suspension of FAs for neurogenic ED may be a wiser choice to achieve steady therapeutic outcome and to reduce risks for the future clinical application. FUND: This work was supported by the National Natural Science Foundation of China (81701432) (to Y. Xu). Youth Training Project for Medical science (16QNP129) and Beijing Nova Program of science and technology (Z171100001117115) (to Z. Liu).

28 April 2023 in Advanced Functional Materials
Verified
Journal Article
Closed access
XDXiaoyu Ding
Xiaoyu Ding
XXXiaowen Xing
Xiaowen Xing
JLJianfeng Liu
Jianfeng Liu
PZPengchong Zhu
Pengchong Zhu
CWCui Wang
Cui Wang
ZLZhiqiang Liu
Zhiqiang Liu